VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $643,160 | -10.7% | 23,900 | 0.0% | 0.29% | -4.2% |
| Q2 2023 | $719,881 | -7.3% | 23,900 | -0.4% | 0.31% | -13.3% |
| Q1 2023 | $776,414 | +112750.9% | 24,000 | 0.0% | 0.35% | +11.7% |
| Q4 2022 | $688 | -99.9% | 24,000 | -0.8% | 0.32% | +20.2% |
| Q3 2022 | $584,000 | -11.9% | 24,200 | 0.0% | 0.26% | +4.8% |
| Q2 2022 | $663,000 | -35.6% | 24,200 | -9.8% | 0.25% | -20.1% |
| Q1 2022 | $1,029,000 | +19.8% | 26,825 | 0.0% | 0.31% | +32.5% |
| Q4 2021 | $859,000 | +6.7% | 26,825 | -1.8% | 0.24% | -6.7% |
| Q3 2021 | $805,000 | -13.3% | 27,325 | 0.0% | 0.25% | -8.3% |
| Q2 2021 | $929,000 | +3.5% | 27,325 | -1.1% | 0.28% | -0.7% |
| Q1 2021 | $898,000 | -9.7% | 27,625 | 0.0% | 0.28% | -11.1% |
| Q4 2020 | $995,000 | -52.6% | 27,625 | -48.5% | 0.31% | -52.8% |
| Q3 2020 | $2,100,000 | -19.7% | 53,630 | -24.8% | 0.66% | -22.9% |
| Q2 2020 | $2,615,000 | +59.3% | 71,280 | 0.0% | 0.86% | -13.6% |
| Q1 2020 | $1,642,000 | -21.3% | 71,280 | 0.0% | 1.00% | +53.2% |
| Q4 2019 | $2,087,000 | +9.6% | 71,280 | 0.0% | 0.65% | +2.8% |
| Q3 2019 | $1,904,000 | +23.7% | 71,280 | +18.4% | 0.63% | +22.9% |
| Q2 2019 | $1,539,000 | +71.2% | 60,205 | +50.1% | 0.52% | +75.5% |
| Q1 2019 | $899,000 | +54.2% | 40,105 | +45.0% | 0.29% | +38.7% |
| Q4 2018 | $583,000 | +13.9% | 27,655 | 0.0% | 0.21% | +36.8% |
| Q3 2018 | $512,000 | -58.5% | 27,655 | -50.0% | 0.16% | -26.5% |
| Q2 2018 | $1,234,000 | +103.0% | 55,310 | +100.0% | 0.21% | -9.4% |
| Q1 2018 | $608,000 | +127.7% | 27,655 | +141.0% | 0.23% | +126.2% |
| Q4 2017 | $267,000 | +1.5% | 11,475 | 0.0% | 0.10% | -4.6% |
| Q3 2017 | $263,000 | +4.0% | 11,475 | 0.0% | 0.11% | -1.8% |
| Q2 2017 | $253,000 | -3.4% | 11,475 | 0.0% | 0.11% | -4.3% |
| Q1 2017 | $262,000 | -61.5% | 11,475 | -64.8% | 0.12% | -38.2% |
| Q4 2016 | $681,000 | -60.3% | 32,560 | -49.8% | 0.19% | -59.9% |
| Q3 2016 | $1,715,000 | – | 64,890 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |